Home›Stocks›IRD

IRD — structural market context

Opus Genetics, Inc. Common Sto

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

IRD short interest & days to cover

SHARES SHORT
10.8M
% OF FLOAT
—
DAYS TO COVER
11.9
CHANGE VS PRIOR
+5.7%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (41d ago)

IRD fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-08-12 · 29d9K$3.88
2026-08-05 · 36d1K$3.71
2026-07-30 · 42d32K$3.47

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

IRD insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 1 sale

InsiderTypeSharesValueFiled
Gagnon Robert E. · officer: Chief Financial OfficerSell (S)28K$127K2026-09-08

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

IRD analyst ratings — with each firm's measured accuracy

FirmActionRatingFirm 5d hit rate*Published
OppenheimerholdOutperformn<302026-09-09
Oppenheimerprice_target—n<302026-09-09
Chardan Capitalprice_target—n<302026-09-09

*Rating actions from public feeds. Where shown, the firm's 5-day hit rate is our measured backtest (firms with >=30 graded calls); a historical hit rate describes past calls, it does not grade this one.

Frequently asked questions

Are insiders buying IRD?
In the last 12 months of SEC Form 4 filings, IRD recorded 0 open-market insider purchases and 1 open-market sale (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about IRD?
The most recent action: Oppenheimer hold to Outperform on 2026-09-09. We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.
Is this page telling me to buy or sell IRD?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with I

IMQCF · Inmobiliaria Colonial Socimi SIONS · Ionis Pharmaceuticals, Inc. CoILMN · Illumina, Inc.INFQ · Infleqtion, Inc.INOD · Innodata Inc.INTC · Intel CorporationAll I →

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.